GSVTX
Price
$16.11
Change
-$0.34 (-2.07%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

GSVTX vs RMFCX

Header iconGSVTX vs RMFCX Comparison
Open Charts GSVTX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value I
Price$16.11
Change-$0.34 (-2.07%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
GSVTX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVTX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVTX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. GSVTX (455M). RMFCX pays higher dividends than GSVTX: RMFCX (1.69) vs GSVTX (1.17). GSVTX was incepted earlier than RMFCX: GSVTX (17 years) vs RMFCX (23 years). GSVTX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). GSVTX has a lower initial minimum investment than RMFCX: GSVTX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. GSVTX (10.33). RMFCX return over 5 years is better than : 40.39 vs. GSVTX (14.31).
GSVTXRMFCXGSVTX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD8.72411.42376%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets455M104B0%
Annual Yield % from dividends1.171.6969%
Returns for 1 year10.3312.6382%
Returns for 3 years5.0114.1635%
Returns for 5 years14.3140.3935%
Returns for 10 years3.5761.846%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc